Accessible Search Form           Advanced Search

6. Institute Public Advisory Committees


National Heart, Lung, and Blood Advisory Council

Structure

Chair: Elizabeth G. Nabel, M.D., Director, NHLBI

Executive Secretary: Stephen C. Mockrin, Ph.D., Director, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0260

The Secretary of HHS appoints 18 members: 12 members are leading representatives of the health and scientific disciplines (including public health and behavioral or social sciences), and 6 are from the general public and are leaders in the fields of public policy, law, health policy, economics, and management.

Members are appointed for overlapping terms of 4 years.

The Council includes the following ex officio members:

  • Secretary, HHS
  • Director, NIH
  • Director, NHLBI
  • Chief Medical Director, or Designee, Veterans Affairs
  • Assistant Secretary of Defense for Health Affairs, or Designee.

Functions

The NHLBAC reviews applications for research grants, cooperative agreements, and training grants in heart, blood vessel, lung, and blood diseases; sleep disorders; and blood resources, and recommends scientific projects that merit support to the Director, NHLBI.

The Council advises the Secretary, HHS, the Assistant Secretary for Health, HHS, and the Directors, NIH and NHLBI, on matters relating to causes, prevention, and methods of diagnosis and treatment of diseases and resources within the purview of the Institute. As stated in its charter, the Council also “may review any grant, contract, or cooperative agreement proposed to be made or entered into by the Institute; may make recommendations to the Director of the Institute respecting research conducted at the Institute; may collect, by correspondence or by personal investigation, information as to studies that are being carried on in the United States or any other country with respect to the cause, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases, and to the use of blood and blood products and the management of blood resources and with the approval of the Director of the Institute, make available such information through appropriate publications for the benefit of public and private health entities and health professions personnel and scientists and for the information of the general public; and may appoint subcommittees and convene workshops and conferences.”

The Council may also make recommendations to the Director, NIH and other authorized officials regarding the acceptance of conditional gifts pursuant to section 2501 of the Public Health Service Act.

Meetings

The Chair convenes meetings not fewer than four times a year and approves the agenda.

Back to Top

National Heart, Lung, and Blood Advisory Council Membership*

Elizabeth G. Nabel, M.D.
Chair
National Heart, Lung, and Blood Institute

Gordon R. Bernard, M.D. (2006)
Vanderbilt University School of Medicine

Roberto Bolli, M.D. (2007)
University of Louisville

Richard C. Boucher, Jr., M.D. (2007)
University of North Carolina at Chapel Hill

Maria R. Costanzo, M.D. (2006)
Edward Cardiovascular Institute

Victor J. Dzau, M.D. (2009)
Duke University

Kim A. Eagle, M.D. (2006)
University of Michigan

Charles T. Esmon, Ph.D. (2008)
Oklahoma Medical Research Foundation

Frances C. Henderson, Ed.D. (2006)
University of Mississippi Medical Center

Katherine A. High, M.D. (2008)
University of Pennsylvania School of Medicine

Helen H. Hobbs, M.D. (2009)
University of Texas Southwestern Medical Center

Jennie R. Joe, M.D., Ph.D. (2009)
University of Arizona

Hoxi J. Jones (2008)
Texas Health and Human Services Commission

Robert F. Lemanske, Jr., M.D. (2007)
University of Wisconsin Hospital

Joseph Loscalzo, M.D., Ph.D. (2009)
Brigham and Women’s Hospital

Jeffrey McCullough, M.D. (2008)
University of Minnesota

Ngai X. Nguyen, M.D. (2006)
Private Practitioner

Patricia W. Wahl, Ph.D. (2008)
University of Washington

Ex Officio Members

Robert L. Jesse, M.D., Ph.D.
McGuire Veterans Affairs Medical Center

Michael O. Leavett
Department of Health and Human Services

Cdr. Richard T. Mahon, M.D.
Naval Medical Research Center

Elias A. Zerhouni, Jr., M.D.
National Institutes of Health

   

* Current as of October 2006. The current roster, containing full addresses for the NHLBI Advisory Council and Committees, can be obtained from the Internet at http://www.nhlbi.nih.gov/about/committees/nhlbac/roster.htm.

Back to Top

Program Advisory and Review Committee

Sickle Cell Disease Advisory Committee

Chair: Floyd D. Armstrong, Ph.D., University of Miami School of Medicine

Executive Secretary: Robert B. Moore, Ph.D., Health Scientist Administrator, Division of Blood Diseases and Resources, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0050

The Sickle Cell Disease Advisory Committee advises the Secretary and the Assistant Secretary for Health, HHS and the Directors of the NIH, the NHLBI, and the DBDR on matters related to the Sickle Cell Disease Program and makes recommendations concerning planning, execution, and evaluation of all aspects of the program.

Membership*

Michael R. DeBaun, M.D. (2007)
Washington University School of Medicine
Johnson Haynes, Jr., M.D. (2007)
University of South Alabama College of Medicine
Frans A. Kuypers, Ph.D. (2008)
Children’s Hospital Oakland Research Institute
Shirley Miller (2008)
Children’s Medical Center of Dallas
Dorothy C. Moore, M.D. (2007)
University of Medicine and Dentistry of New Jersey
Eugene P. Orringer, M.D. (2008)
University of North Carolina at Chapel Hill
Russell E. Ware, M.D., Ph.D. (2006)
St. Jude Children’s Research Hospital
   

Ex Officio Members

Joseph Desimone, Ph.D.
Department of Veterans Administration, Chicago
Marie C. Earley, Ph.D.
Centers for Disease Control and Prevention
Marie Y. Mann, M.D.
Health Resources and Services Administration
Robert L. Sheffler, M.D.
Tripler Army Medical Center
Elias A. Zerhouni, Jr., M.D.
National Institutes of Health

Back to Top

Sleep Disorders Research Advisory Board

Chair: Phyllis C. Zee, M.D., Ph.D., Northwestern University Medical School

Executive Secretary: Michael J. Twery, Ph.D., Acting Director, National Center on Sleep Disorders Re-search, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0202.

The Sleep Disorders Research Advisory Board advises the Directors of the NIH, the NHLBI, and the NCSDR on matters related to the scientific activities carried out by and through the Center and policies regarding such activities, including the identification of research priorities for coordination of sleep and sleep disorders research by the NIH and other federal, professional, and voluntary organizations.

Membership*

Sonia Ancoli-Israel, Ph.D. (2010)
University of California, San Diego School of Medicine
Sheila C. Connolly, R.N. (2007)
Restless Legs Syndrome Foundation
Estelle B. Gauda, M.D. (2010)
Johns Hopkins University School of Medicine
Elizabeth M. Johns (2008)
Patient Advocate for Sleep-Disordered Breathing
F. Javier Nieto, M.D., Ph.D. (2010)
University of Wisconsin School of Medicine
Gina R. Poe, Ph.D. (2007)
University of Michigan Medical Center
Stuart F. Quan, M.D. (2008)
University of Arizona College of Medicine
Howard P. Roffwarg, M.D. (2009)
University of Mississippi Medical Center
Michael H. Smolensky, Ph.D. (2008)
University of Texas
Lorraine L. Wearley, Ph.D. (2007)
Lorraine Wearley Consulting, LLC
   

Ex Officio Members

Elizabeth G. Nabel, M.D.
NHLBI, National Institutes of Health
Thomas J. Balkin, Ph.D.
Walter Reed Army Institute of Research
Cristina Beato, M.D.
Department of Health and Human Services
Robert W. Greene, M.D., Ph.D.
Veterans Administration, North Texas Medical Center
Merrill M. Mitler, Ph.D.
NINDS, National Institutes of Health
Andrew Monjan, Ph.D.
NIA, National Institutes of Health
Michael J. Twery, Ph.D.
NCSDR, National Institutes of Health
Marian Willinger, Ph.D.
NICHD, National Institutes of Health
Elias A. Zerhouni, Jr., M.D.
National Institutes of Health

Back to Top

Heart, Lung, and Blood Initial Review Group

Scientific Review Administrator: Jeffery H. Hurst, Ph.D., Health Science Administrator, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0303

The Heart, Lung, and Blood Initial Review Group provides initial technical merit review for the NHLBAC and the Director, NHLBI. This group consists of two subcommittees: the Heart, Lung, and Blood Program Project Review Committee and the Clinical Trials Review Committee.

Heart, Lung, and Blood Program Project Review Committee

Chair: Donna Przepiorka, M.D., Ph.D., University of Tennessee College of Medicine

Scientific Review Administrator: Jeffery H. Hurst, Ph.D., Health Scientist Administrator, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0303

The Heart, Lung, and Blood Program Project Review Committee provides initial technical merit review for the NHLBAC and the Director, NHLBI on program project applications proposing research in the areas of heart, lung, and blood diseases and resources.

Membership*

Edward Abraham, M.D. (2009)
University of Alabama at Birmingham
Peng-Sheng Chen, M.D. (2010)
Cedars-Sinai Medical Centera
Louis J. Dell’Italia, M.D. (2008)
University of Alabama
Kathy K. Griendling, Ph.D. (2008)
Emory University
Samuel Hawgood, M.D. (2010)
University of California, San Francisco
Joseph R. Haywood, Ph.D. (2007)
Michigan State University
Timothy T. Hla, Ph.D. (2008)
University of Connecticut School of Medicine
Sriram Krishnaswamy, Ph.D. (2009)
Children’s Hospital of Philadelphia
Renee C. LeBoeuf, Ph.D. (2007)
University of Washington School of Medicine
Diane J. Nugent, M.D. (2009)
University of California, Los Angeles
Jose M. Ordovas, Ph.D. (2007)
Tufts University
Bruce R. Pitt, Ph.D. (2009)
Universitiy of Pittsburgh
Howard A. Rockman, M.D. (2008)
Duke University Medical Center
Ann Marie Schmidt, M.D., Ph.D. (2010)
Columbia University
Susan S. Smyth, M.D., Ph.D. (2009)
University of Kentucky
Robert A. Wise, M.D. (2010)
Johns Hopkins University School of Medicine
Katherine E. Yutzey, Ph.D. (2010)
Children’s Hospital Research Foundation
 

Back to Top

Clinical Trials Review Committee

Chair: Ileana L. Pina, M.D., Case Western Reserve University

Scientific Review Administrator: Patricia A. Haggerty, Ph.D., Health Science Administrator, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0288

The Clinical Trials Review Committee provides initial technical merit review for the NHLBAC and the Director of the NHLBI on clinical trial applications for the support of studies to evaluate preventive or therapeutic measures of blood, cardiovascular, or lung diseases.

Membership*

Walter T. Ambrosius, Ph.D. (2010)
Wake Forest University
Antonio Anzueto, M.D. (2008)
University of Texas Health Science Center at San Antonio
Ulrika M. Birgersdotter-Green, M.D. (2009)
University of California, San Diego
Ivan Chan, Ph.D. (2010)
Merck Research Laboratories
John E. Connett, Ph.D. (2007)
University of Minnesota
Robert M. Elashoff, Ph.D. (2007)
University of California, Los Angeles
Terry B. Gernsheimer, M.D. (2009)
University of Washington School of Medicine
Robert A. Harrington, M.D. (2010)
Duke School of Medicine
John B. Kostis, M.D. (2008)
University of Medicine and Dentistry of New Jersey
Cora E. Lewis, M.D. (2008)
University of Alabama at Birmingham
Pamela Ouyang, M.D. (2010)
Johns Hopkins University School of Medicine
Julio A. Panza, M.D. (2009)
Washington Hospital Center
Lynda H. Powell, Ph.D. (2007)
Rush-Presbyterian-St. Luke’s Medical Center
John J. Reilly, M.D. (2009)
Brigham and Women’s Hospital
Alexis A. Thompson, M.D. (2008)
Northwestern University Medical School

National Heart, Lung, and Blood Institute Special Emphasis Panel

The Institute has established the NHLBI Special Emphasis Panel (SEP) to perform initial peer review of applications and proposals that were previously handled by ad hoc committees. Concept review, previously handled by divisional program advisory committees, has also been incorporated into the SEP system. The SEP, which has neither a fixed membership nor a set meeting schedule, is constituted to provide required peer review expertise at precisely the time that it is needed.

Board of Scientific Counselors

Chair: Ivor J. Benjamin, M.D., University of Utah Health Sciences Center

Executive Secretary: Robert S. Balaban, Ph.D., Director, Laboratory Research Program, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–496–2116

The Board of Scientific Counselors advises the Director and the Deputy Director for Intramural Research, NIH, and the Directors of NHLBI and the Division of Intramural Research, NHLBI, on the intramural research programs of the NHLBI.

Membership*

Nancy Berliner, M.D. (2007)
Yale University School of Medicine
Stephen Black, Ph.D. (2011)
Medical College of Georgia
Eduardo Marban, M.D., Ph.D. (2011)
Johns Hopkins University
Elizabeth M. McNally, M.D., Ph.D. (2010)
University of Chicago
Gary K. Owens, M.D., Ph.D. (2010)
University of Virginia School of Medicine
Edwin W. Taylor, Ph.D. (2009)
University of Chicago
Alan S. Verkman, M.D., Ph.D. (2009)
University of California, San Francisco
Sally E. Wenzel-Morganroth, M.D. (2007)
National Jewish and Medical Research Center
 

* Current as of October 2006.

Back to Top

« Back

Next »

Fact Book Table of Contents

Twitter iconTwitterimage of external icon Facebook iconFacebookimage of external icon YouTube iconYouTubeimage of external icon Google+ iconGoogle+image of external icon